A single blood test could help doctors predict how lung cancer patients will respond to treatment before therapy begins, ...
Cancer scientists have discovered that lung cancer cells can change their identity to resist treatment. Research published today [27 May] in Molecular Oncology reveals how lung cancer cells can become ...
12hon MSN
Lung cancer cells can revert identity to a branching state, fueling resistance and aggressive growth
Oncologists have discovered that lung cancer cells can change their identity to resist treatment. Research published in Molecular Oncology reveals how lung cancer cells can become more aggressive and ...
New drugs have made America’s deadliest cancer more treatable than ever. So why aren’t they reaching patients?
This segment is brought to you by LCFAmerica. A new treatment option, SubQ, is helping some lung cancer patients spend less ...
Abenacianine, a fluorescent imaging agent, received FDA fast track status for enhancing tumor visualization during lung cancer surgery, showing safety and efficacy in phase 2 trials. Alecensa ...
Squamous cell carcinoma treatment varies by stage, involving surgery, radiation, and systemic therapies based on cancer progression and patient health. Stage 1 focuses on tumor removal, Stage 2 ...
Marie Francillion was diagnosed with lung cancer after she was feeling heartburn and shoulder pain. She said she's able to ...
(Reuters) -AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat a type of lung cancer, marking the first approval of the therapy ...
Scientists, funded by Cancer Research UK, have now passed another hurdle, bringing the test closer to patient use ...
Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results